Human clinical trials have not started, so we don't know whether it will be safe, effective, or outperform existing GLP-1 medications
Unfortunately, many people with Hashimotos even if eating adequate amounts of protein in their diet dont digest protein well, nor do their bodies extract these nutrients efficiently
The labels of Wegovy and a diabetes drug called Mounjaro acknowledge reports of intestinal blockage in some people who use them
To put this in perspective: if you weigh 200 pounds, tirzepatide helped people lose an average of 50.3 pounds, versus 33.1 pounds with semaglutide
If you miss a dose of oral semaglutide, youll typically need to wait until the next morning to take your next dose (unless directed otherwise by your prescriber)
For arthritis and musculoskeletal pain, the data can be summarized in one sentence: There is no credible human evidence that BPC-157 works, and real risks exist due to poor-quality manufacturing and illegal distribution